Ticker

BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) said on Tuesday an abstract from its mid-stage study of experimental Parkinson's disease treatment bezisterim has been accepted for presentation at an upcoming neurology conference. The abstract, based on the company's SUNRISE-PD trial evaluating bezisterim in patients with early Parkinson's disease, will be presented at the American Academy of Neurology Annual Meeting later…

CARSON CITY, Nev., April 14, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced the acceptance of an abstract from its SUNRISE-PD study on lead candidate bezisterim (NE3107) in the treatment of patients with Parkinson's Disease at the upcoming American Academy…

United Airlines Holdings Inc (NASDAQ:UAL, XETRA:UAL1) and American Airlines Group Inc (NASDAQ:AAL, XETRA:A1G) have been drawn into merger speculation...

Shares of Conagra Brands Inc (NYSE:CAG) were down more than 5.6% on Monday after the packaged food company announced that CEO Sean Connolly will step down....

Shares in RS Group (LSE: RS1), the industrial electronics and maintenance products distributor, fell almost 3% after Deutsche Bank downgraded the stock from...